Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
US Department of Justice
Moodys
Covington
Baxter
US Army
Medtronic
Argus Health
Daiichi Sankyo

Generated: September 24, 2018

DrugPatentWatch Database Preview

PREDNISOLONE TEBUTATE - Generic Drug Details

« Back to Dashboard

What are the generic sources for prednisolone tebutate and what is the scope of prednisolone tebutate freedom to operate?

Prednisolone tebutate is the generic ingredient in two branded drugs marketed by Merck and Watson Labs, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are eighty-seven drug master file entries for prednisolone tebutate.

Summary for PREDNISOLONE TEBUTATE
US Patents:0
Tradenames:2
Applicants:2
NDAs:2
Drug Master File Entries: 87
Bulk Api Vendors: 14
Patent Applications: 1,557
DailyMed Link:PREDNISOLONE TEBUTATE at DailyMed
Synonyms for PREDNISOLONE TEBUTATE
(11beta)-11,17-dihydroxy-3,20-dioxopregna-1,4-dien-21-yl 3,3-dimethylbutanoate
[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] 3,3-dimethylbutanoate
[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 3,3-dimethylbutanoate
11beta,17,21-Trihydroxypregna-1,4-diene-3,20-dione 21-(3,3-dimethylbutyrate)
1V7A1U282K
2-[(1S,2R,10S,11S,14R,15S,17S)-14,17-DIHYDROXY-2,15-DIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIEN-14-YL]-2-OXOETHYL 3,3-DIMETHYLBUTANOATE
681P143
7681-14-3
AC1L3PEP
C08182
C27H38O6
CAS-7681-14-3
CHEBI:8381
CHEMBL1200909
CS-7134
D00982
DSSTox_CID_3505
DSSTox_GSID_23505
DSSTox_RID_97549
DTXSID8023505
EINECS 231-661-5
HY-U00098
Hydeltra-T.B.A
Hydeltra-T.B.A.
Hydeltra-TBA (TN)
LS-177301
NCGC00249886-01
PL009239
Predalone T.B.A
Prednisolone 21-tert-butylacetate
Prednisolone butyl acetete
Prednisolone Butylacetate
Prednisolone TBA
Prednisolone tebutate (JAN/USP)
Prednisolone tebutate [USP]
prednisolone tert-butylacetate
Pregna-1,4-diene-3,20-dione, 11,17-dihydroxy-21-((3,3-dimethyl-1-oxobutyl)oxy)-, (11beta)-
pregna-1,4-diene-3,20-dione, 21-(3,3-dimethyl-1-oxobutoxy)-11,17-dihydroxy-, (11 beta)-
Pregna-1,4-diene-3,20-dione, 21-(3,3-dimethyl-1-oxobutoxy)-11,17-dihydroxy-, (11beta)-
SCHEMBL40845
Tox21_113662
UNII-1V7A1U282K
V1327
ZINC4097474

US Patents and Regulatory Information for PREDNISOLONE TEBUTATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs PREDNISOLONE TEBUTATE prednisolone tebutate INJECTABLE;INJECTION 083362-001 Feb 17, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Merck HYDELTRA-TBA prednisolone tebutate INJECTABLE;INJECTION 010562-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
US Department of Justice
Moodys
Covington
Baxter
US Army
Medtronic
Argus Health
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.